Siegel CA, Melmed GY, McGovern DP, et al. Full text link: SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting Gut Published Online First: 20 January 2021. doi: 10.1136/gutjnl-2020-324000
In the article, they note “the exception is for any live-attenuated virus vaccines or replication-competent viral vector vaccines that come to market.” Currently, all of the vaccines are inactivated (not live-attenuated).
These recommendations apply to approved populations which currently do not include pediatric patients or patients who are pregnant.
Related blog posts:
- NPR Story: How Clinic Staff Decided to Accept COVID-19 Vaccine
- COVID-19 -How India Turned Things Around & Vaccine Information for Patients
- Visual Data of Pfizer COVID-19 Vaccine
- Expert Update on COVID-19 Pandemic and Vaccine Rollout
From Children’s Healthcare of Atlanta: